Santander

Santander GHP Br

Borrower (s)
Santander
Industry
Other/Healthcare
Area of finance
Development Bank Finance
Region
Latin America
Countries
Brazil

Deal Overview

The indicative proposed investment consists of a 3-year loan of up to US$150 million to Banco Santander (Brasil) S.A. (“Santander” or the “Bank”), an existing IFC client since 2009. The Project aims to support the Bank’s consumer finance lending to healthcare services...

show more

The indicative proposed investment consists of a 3-year loan of up to US$150 million to Banco Santander (Brasil) S.A. (“Santander” or the “Bank”), an existing IFC client since 2009. The Project aims to support the Bank’s consumer finance lending to healthcare services Micro, Small and Medium Enterprises (“MSMEs”) as well as doctors and health professionals to purchase medical equipment (“MedTech”) to meet the increased service demand to fight COVID and further equipping the Brazilian health system for future resilience (“the Project”). In addition, up to 30 percent of the loan may be used to finance working capital needs for MSMEs (MedTech manufacturers or distributors and healthcare services providers). As a result of the proposed use of proceeds, this Project is processed under the Global Health Platform (“GHP”), a US$4 billion IFC program with the objective of mobilizing private investment to close the healthcare supply gaps in the wake of Covid-19.

show less
Deal Volume
$ 150m
Financial Close
17 March 2022
Sources

All Dealmakers

Tranches


To view all tranche and pricing information, please sign up or log in